A case of karyomegalic interstitial nephritis without FAN1 mutations in the setting of brentuximab, ifosfamide, and carboplatin exposure
Related Posts
Ebrahimi N, Ha V, Glassock RJ, Rastogi A, Norouzi S. Inebilizumab Monotherapy in Relapsing IgG4-Related Tubulointerstitial Nephritis. Kidney Int Rep. 2026 Aug 24;11(11):107055. doi: 10.1016/j.ekir.2026.107055.[...]
Htoo PT, Patorno E, Ortega-Montiel J, Wexler DJ, Orkaby A, Paik JM. Comparative Renal Effectiveness of GLP-1RA and SGLT2i in US Veterans with Type 2[...]
Goshtaseb R, Luu Y, Sarmosyan K, Lopez L, Drakaki A. Suspected Pembrolizumab-Associated Perinuclear Antineutrophil Cytoplasmic Antibody (p-ANCA) Vasculitis With Progressive Kidney Injury in a Patient[...]